Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
7.50
-0.07 (-0.92%)
At close: Apr 1, 2025, 4:00 PM
7.54
+0.04 (0.57%)
After-hours: Apr 1, 2025, 7:56 PM EDT

Cullinan Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
439709436483674-
Upgrade
Market Cap Growth
62.69%62.69%-9.73%-28.36%--
Upgrade
Enterprise Value
42134-25-88355-
Upgrade
Last Close Price
7.5012.1810.1910.5515.43-
Upgrade
PE Ratio
---4.34--
Upgrade
PS Ratio
---35.58-
Upgrade
PB Ratio
0.741.200.960.901.59-
Upgrade
P/TBV Ratio
1.201.200.960.901.59-
Upgrade
EV/Sales Ratio
---18.75-
Upgrade
Debt / Equity Ratio
0.000.000.010.01--
Upgrade
Asset Turnover
----0.06-
Upgrade
Quick Ratio
13.2313.2316.6020.7724.7314.68
Upgrade
Current Ratio
13.5313.5317.0721.0925.2514.82
Upgrade
Return on Equity (ROE)
-32.10%-32.10%-31.37%22.74%-21.57%-39.88%
Upgrade
Return on Assets (ROA)
-22.26%-22.26%-22.80%-16.55%-13.03%-23.93%
Upgrade
Return on Capital (ROIC)
-23.44%-23.44%-23.89%-17.11%-13.58%-25.29%
Upgrade
Earnings Yield
-38.14%-23.60%-35.13%23.03%-9.73%-
Upgrade
FCF Yield
-33.11%-20.49%-30.85%-26.46%-6.44%-
Upgrade
Buyback Yield / Dilution
-29.41%-29.41%10.91%-8.27%-116.61%-2088.17%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q